What is NDC 51662-1652?

51662-1652 is the product NDC for GLYDO- lidocaine hydrochloride jelly, Lidocaine hydrochloride anhydrous 20 mg/mL jelly, listed with the FDA by HF Acquisition Co. LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.

What is the active ingredient?

Lidocaine hydrochloride anhydrous.

HF Acquisition Co. LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for GLYDO- lidocaine hydrochloride jelly?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

GLYDO- lidocaine hydrochloride jelly NDC 51662-1652

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1652Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1652Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1652-1	5166216520151662165201	1 SYRINGE in 1 SYRINGE (51662-1652-1) / 6 mL in 1 SYRINGEMarketed from Sep 15, 2014

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): GLYDO- lidocaine hydrochloride jelly
Generic name (nonproprietary): glydo- lidocaine hydrochloride jelly
Active ingredients: Lidocaine hydrochloride anhydrous — 20 mg/mL
Dosage form: Jelly
Route: Topical
Labeler: HF Acquisition Co. LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201094
Marketing start: Sep 15, 2014
Listing expires: Dec 31, 2026
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 51662-1652_3364b25d-bf31-c028-e063-6394a90a8008SPL ID 3364b25d-bf31-c028-e063-6394a90a8008SPL set ID 3364b25d-bf30-c028-e063-6394a90a8008RxCUI 1011852UNII EC2CNF7XFP
Pharmacologic class: Amide Local Anesthetic; Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451662165201 followed by a unit qualifier and the quantity

Package 51662-1652-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 22, 2025.

Indications (excerpt from the label)

GLYDO 2% Jelly is indicated for prevention and control of pain in procedures involving the male and female urethra, for topical treatment of painful urethritis, and as an anesthetic lubricant for endotracheal intubation (oral and nasal).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1652

What is NDC 51662-1652?: 51662-1652 is the product NDC for GLYDO- lidocaine hydrochloride jelly, Lidocaine hydrochloride anhydrous 20 mg/mL jelly, listed with the FDA by HF Acquisition Co. LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: GLYDO- lidocaine hydrochloride jelly.
What is the active ingredient?: Lidocaine hydrochloride anhydrous.
Who is the labeler?: HF Acquisition Co. LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for GLYDO- lidocaine hydrochloride jelly?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under ANDA 201094

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201094
Product	Strength	Form · route	Labeler	Product NDC
glydolidocaine hydrochloride	Lidocaine hydrochloride anhydrous 20 mg/mL	JellyTopical	Sagent Pharmaceuticals	25021-673